DUBLIN--(BUSINESS WIRE)--The "Global Viral Partnering 2012-2018: Deal trends, players and financials" report has been added to ResearchAndMarkets.com's offering.
Global Viral Partnering 2012 to 2018 provides the full collection of Viral disease deals signed between the world's pharmaceutical and biotechnology companies since 2012.
Most of the deals included within the report occur when a licensee obtains a right or an option right to license a licensor's product or technology. More often these days these deals tend to be multi-component including both a collaborative R&D and a commercialization of outcomes element.
The report takes readers through the comprehensive Viral disease deal trends, key players and top deal values allowing the understanding of how, why and under what terms companies are currently entering Viral deals.
The report presents financial deal terms values for Viral deals, where available listing by overall headline values, upfront payments, milestones and royalties enabling readers to analyse and benchmark the value of current deals.
In addition, a comprehensive appendix is provided with each report of all Viral partnering deals signed and announced since 2012. The appendices are organized by company A-Z, stage of development at signing, deal type (collaborative R&D, co-promotion, licensing etc) and technology type. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.
In conclusion, this report provides everything a prospective dealmaker needs to know about partnering in the research, development and commercialization of Viral technologies and products.
Key Topics Covered:
Chapter 1 - Introduction
Chapter 2 - Trends in Viral dealmaking
Chapter 3 - Financial deal terms for Viral partnering
Chapter 4 - Leading Viral deals and dealmakers
Chapter 5 - Viral contract document directory
Chapter 6 - Viral dealmaking by therapeutic target
For more information about this report visit https://www.researchandmarkets.com/research/rm5vtz/global_viral?w=4